Coinbase Stock Drops as Baird Warns of Weak Crypto Trading Volumes and Valuation Risks

Coinbase Global shares fell sharply on Friday after Baird lowered its price target and warned that weak cryptocurrency trading volumes could continue to pressure the company’s revenue outlook.

The stock dropped nearly 7% to around $152 after Baird kept a Neutral rating on Coinbase but cut its price target from $160 to $142. The firm also named Coinbase a “Bearish Fresh Pick,” pointing to softer trading activity, possible second-quarter revenue weakness, and concerns that the stock’s valuation remains stretched.

Baird Sees Revenue Pressure From Slower Trading

Although Coinbase has worked to expand beyond trading fees, transaction revenue still remains a major part of its business. Baird analyst David Koning said Coinbase’s second-quarter revenue could come in about 5% to 6% below Wall Street expectations.

The concern is mainly tied to falling crypto trading volumes. Baird expects Coinbase trading volumes to decline 15% to 20% compared with the previous quarter. April and May were described as especially weak months for crypto activity, even though early June showed some improvement.

Crypto Market Activity Remains Subdued

Baird said the recent bounce in June trading may not be strong enough to prove a full recovery. The firm suggested that some of the activity may have come from investors rotating out of Bitcoin rather than from broad, lasting demand across the crypto market.

Several wider market factors are also weighing on Coinbase. These include higher borrowing costs, inflation worries, strong performance in traditional equities, and investor interest shifting toward other growth themes such as artificial intelligence stocks and new IPO opportunities.

Regulatory Uncertainty Adds Another Risk

Another concern is uncertainty around the proposed CLARITY Act, a crypto market-structure bill supported by many in the digital asset industry. Baird warned that political disagreements could delay progress on the legislation before the November midterm elections.

A delay could hurt crypto exchanges like Coinbase because banks and fintech companies may benefit from operating under clearer existing rules. For Coinbase, slower regulatory progress may mean slower institutional adoption and weaker investor confidence.

Valuation Concerns Put More Pressure on Coinbase

Baird also raised concerns about Coinbase’s valuation. The firm noted that the stock trades at about 35 times estimated 2027 earnings per share. If earnings estimates fall and investors become less willing to pay high multiples for fintech stocks, Coinbase’s valuation could face more pressure.

In Baird’s bear-case scenario, Coinbase shares could fall to between $75 and $90 if 2027 earnings per share decline to around $3 and the stock’s valuation multiple contracts to 25 to 30 times earnings.

Wall Street Remains More Optimistic Overall

Despite Baird’s cautious view, the broader analyst community is still more positive on Coinbase. According to FactSet data cited in the report, about 64% of the 39 analysts covering Coinbase rate the stock as a Buy, with an average price target near $231.

This shows a clear split in market opinion. Bulls believe Coinbase can benefit from long-term crypto adoption, regulatory clarity, and growth in non-trading revenue. Bears argue that weak trading volumes, high valuation, and regulatory delays could limit upside in the near term.

What It Means for Investors

The latest decline shows how sensitive Coinbase remains to crypto trading activity. When market participation slows, Coinbase’s revenue outlook can weaken quickly. While the company has built new business lines, trading fees still play a central role in its financial performance.

For investors, the key questions are whether crypto volumes recover in a sustainable way, whether regulatory reform moves forward, and whether Coinbase can grow enough outside trading to support its valuation.

Source: Invezz report published on June 5, 2026.

#Coinbase #COINStock #CryptoNews #StockMarket #SlimScan #GrowthStocks #CANSLIM